Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05074186 · ClinicalTrials.gov registry record · NA

Assessing the Safety and Effectiveness of a Neurological Thrombectomy Medical Device for Acute Ischemic Stroke

A NA study of Ischemic Stroke, sponsored by Jacobs institute.

Completed
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT05074186 is a NA study of Ischemic Stroke that has completed, run by Jacobs institute. The registered enrollment target is 8 participants, below the 1,464-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05074186, a NA study of Ischemic Stroke, has completed, sponsored by Jacobs institute.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

The Jacobs Institute is participating in a Sponsor Investigator study designed to collect prospective clinical evidence to evaluate the use of a neurological thrombectomy device for clot retrieval in acute ischemic patients

Conditions Studied

Interventions

  • DEVICE neurological thrombectomy device is an investigational device.

Study Locations (1)

New York

  • kaledia Health/Buffalo General Medical Center/GVI - Buffalo

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2021-06-08
Est. Completion 2024-07-30
Phase NA

Sponsor

Jacobs institute

5 total trials

What the Registry Record Tells You About NCT05074186

The ClinicalTrials.gov registry entry for NCT05074186 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,464-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Jacobs institute, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which neurological thrombectomy device is an investigational device. is the first listed.

NCT05074186 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05074186 about?

NCT05074186 is a clinical study titled "Assessing the Safety and Effectiveness of a Neurological Thrombectomy Medical Device for Acute Ischemic Stroke". The Jacobs Institute is participating in a Sponsor Investigator study designed to collect prospective clinical evidence to evaluate the use of a neurological thrombectomy device for clot retrieval in acute ischemic patients

What is the current status of trial NCT05074186?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2021-06-08. Estimated completion is 2024-07-30.

What conditions does trial NCT05074186 study?

This clinical trial studies the following conditions: Ischemic Stroke.

What interventions are being tested in trial NCT05074186?

The interventions under investigation include: neurological thrombectomy device is an investigational device. (DEVICE).

Who is sponsoring clinical trial NCT05074186?

This trial is sponsored by Jacobs institute, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05074186 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.